Namsa Acquires Uk-Based Perfectus Biomed Group To Enhance Customized Microbiological Solutions
10/04/22, 2:32 PM
Industry
medical device
biotechnology
health care
manufacturing
NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group, a UK-based laboratory providing customized microbiological services.
Company Info
Company info
NAMSA is a world-leading MedTech testing, clinical, and regulatory consulting firm dedicated to accelerating medical device product development. With a deep pool of testing, clinical, and regulatory experts, NAMSA helps medical device sponsors improve healthcare and is committed to enhancing stakeholder value through strategic outsourcing and comprehensive in-house services.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Bh
Bh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more